EUVIMEDEUVIMED entdecken
Crossref

Factors Associated With Clinical Trial Participation in Adult Hematopoietic Stem Cell Transplantation Recipients: A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis

Tamryn L Fowler, Ruta Brazauskas, Jinalben Patel, Hemalatha G Rangarajan, Fotios V Michelis, Minoo Battiwalla, Leslie E Lehmann, Heather E Stefanski, Ajoy L Dias, Akshay Sharma, Amer Beitinjaneh, Amer M Zeidan und 32 weitere

Journal of the National Comprehensive Cancer Network · 2026-11 · 24 (11)

DOI: 10.6004/jnccn.2026.7054 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2026-11. Verfasst von Tamryn L Fowler und 43 weiteren Autor:innen. Beteiligte Einrichtung: 1School of Nursing, University of North Carolina at Chapel Hill, Chapel Hill, NC. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Clinical Trials as Topic, Patient Participation. Die Arbeit nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Only 3%–5% of patients with cancer nationwide enroll in clinical trials. Although participation among patients with solid tumors has been well studied, data in the hematopoietic stem cell transplantation (HSCT) setting remain limited. We sought to (1) describe clinical trial participation rates by HSCT type; (2) examine associations between patient, disease, and transplant characteristics and trial participation; and (3) explore the association between trial participation and overall survival (OS).

Methods

We conducted a retrospective study using Center for International Blood and Marrow Transplant Research (CIBMTR) data from US adults aged 18–75 years who underwent autologous or allogeneic HSCT between 2013 and 2019 (N=84,151; autologous: n=51,133; allogeneic: n=33,018). Logistic regression models assessed predictors of participation, while Cox models evaluated associations with OS.

Results

Trial participation was 2.0% among patients undergoing autologous HSCT and 11.1% among those undergoing allogeneic HSCT. Among autologous recipients, greater comorbidity burden was associated with lower odds of participation. Patients with multiple myeloma had higher odds than those with non-Hodgkin lymphoma (odds ratio [OR], 1.25; P =.01). Among allogeneic recipients, older adults had higher odds of participation (eg, OR, 2.19 for age ≥70 vs 18–19 years; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationClinical Trials as TopicPatient ParticipationHumansAdultMiddle AgedFemaleMaleYoung AdultAdolescentAgedRetrospective StudiesTransplantation, HomologousTransplantation, Autologous

Stichwörter der Autor:innen

Health disparitiesadult oncologyclinical trial participationdecision-makinghematopoietic stem cell transplantation

Autor:innen und Institutionen

  • 1School of Nursing, University of North Carolina at Chapel Hill, Chapel Hill, NC.
  • 2Division of Biostatistics, Data Science Institute, Medical College of Wisconsin, Milwaukee, WI.
  • 3CIBMTR(Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI.
  • 4Department of Pediatric Hematology, Oncology, Blood and Marrow Transplantation, Nationwide Children's Hospital, Columbus, OH.
  • 5Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • 6Sarah Cannon Transplant and Cell Therapy Network, Nashville, TN.

Zitieren

APA

Fowler, T. L., Brazauskas, R., Patel, J., Rangarajan, H. G., Michelis, F. V., Battiwalla, M., Lehmann, L. E., Stefanski, H. E., Dias, A. L., Sharma, A., Beitinjaneh, A., Zeidan, A. M., Gómez-De León, A., Saad, A., Hamilton, B. K., Marks, D. I., Rizzieri, D. A., Szwajcer, D., Lad, D. P., …, & Saber, W. (2026). Factors Associated With Clinical Trial Participation in Adult Hematopoietic Stem Cell Transplantation Recipients: A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis. Journal of the National Comprehensive Cancer Network, 24(11). https://doi.org/10.6004/jnccn.2026.7054

Vancouver

Fowler TL, Brazauskas R, Patel J, Rangarajan HG, Michelis FV, Battiwalla M, et al. Factors Associated With Clinical Trial Participation in Adult Hematopoietic Stem Cell Transplantation Recipients: A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis. Journal of the National Comprehensive Cancer Network. 2026;24(11). doi:10.6004/jnccn.2026.7054

BibTeX
@article{Fowler2026,
  author = {Fowler, Tamryn L and Brazauskas, Ruta and Patel, Jinalben and Rangarajan, Hemalatha G and Michelis, Fotios V and Battiwalla, Minoo and Lehmann, Leslie E and Stefanski, Heather E and Dias, Ajoy L and Sharma, Akshay and Beitinjaneh, Amer and Zeidan, Amer M and Gómez-De León, Andrés and Saad, Ayman and Hamilton, Betty K and Marks, David I and Rizzieri, David A and Szwajcer, David and Lad, Deepesh P and Hildebrandt, Gerhard C and Hashem, Hasan and Murthy, Hemant S and Liu, Hongtao and Preussler, Jaime M and Yared, Jean A and Aljurf, Mahmoud and de Lima, Marcos and Krem, Maxwell M and Herr, Megan M and Solh, Melhem and Abid, Muhammad Bilal and Ramanathan, Muthalagu and El Jurdi, Najla and Khera, Nandita and Majhail, Navneet S and Lulla, Premal and Seo, Sachiko and Hong, Sanghee and Chhabra, Saurabh and Ganguly, Siddhartha and Gergis, Usama and Agrawal, Vaibhav and El-Jawahri, Areej R and Saber, Wael},
  title = {Factors Associated With Clinical Trial Participation in Adult Hematopoietic Stem Cell Transplantation Recipients: A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis},
  journal = {Journal of the National Comprehensive Cancer Network},
  year = {2026},
  volume = {24},
  number = {11},
  doi = {10.6004/jnccn.2026.7054}
}
Kostenlos starten →